@pmozgunov.bsky.social
Save the date! Adaptive and Bayesian Designs in Practice!
I am happy to share that I will be organizing a two-day workshop in Cambridge on the application of adaptive and Bayesian designs in practice!
More information is here: lnkd.in/gNEMGfJZ
Let me know if any questions and see you there!
I am happy to share that I will be organizing a two-day workshop in Cambridge on the application of adaptive and Bayesian designs in practice!
More information is here: lnkd.in/gNEMGfJZ
Let me know if any questions and see you there!
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
March 1, 2025 at 5:39 AM
Save the date! Adaptive and Bayesian Designs in Practice!
I am happy to share that I will be organizing a two-day workshop in Cambridge on the application of adaptive and Bayesian designs in practice!
More information is here: lnkd.in/gNEMGfJZ
Let me know if any questions and see you there!
I am happy to share that I will be organizing a two-day workshop in Cambridge on the application of adaptive and Bayesian designs in practice!
More information is here: lnkd.in/gNEMGfJZ
Let me know if any questions and see you there!
A new paper on personalised MTD identification!
In Phase I, all patients are assumed to have the same risk of adverse events. What if it might depend on baseline characteristics?
Can we add covariates when the small sample is small?
The answer is here
onlinelibrary.wiley.com/doi/10.1002/...
In Phase I, all patients are assumed to have the same risk of adverse events. What if it might depend on baseline characteristics?
Can we add covariates when the small sample is small?
The answer is here
onlinelibrary.wiley.com/doi/10.1002/...
On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
There is a growing number of Phase I dose-finding studies that use a model-based approach, such as the CRM or the EWOC method to estimate the dose-toxicity relationship. It is common to assume that a...
onlinelibrary.wiley.com
January 25, 2025 at 8:15 PM
A new paper on personalised MTD identification!
In Phase I, all patients are assumed to have the same risk of adverse events. What if it might depend on baseline characteristics?
Can we add covariates when the small sample is small?
The answer is here
onlinelibrary.wiley.com/doi/10.1002/...
In Phase I, all patients are assumed to have the same risk of adverse events. What if it might depend on baseline characteristics?
Can we add covariates when the small sample is small?
The answer is here
onlinelibrary.wiley.com/doi/10.1002/...
I am looking for a PhD student in Medical Statistics. This project aims to develop new methods for design of early phase trials starting from monotherapy and progressing into combinations. More details are in the link. Feel free to contact me if any questions. www.findaphd.com/phds/project...
Designs for sequences of early phase (modular) studies at University of Cambridge on FindAPhD.com
PhD Project - Designs for sequences of early phase (modular) studies at University of Cambridge, listed on FindAPhD.com
www.findaphd.com
November 26, 2024 at 11:51 AM
I am looking for a PhD student in Medical Statistics. This project aims to develop new methods for design of early phase trials starting from monotherapy and progressing into combinations. More details are in the link. Feel free to contact me if any questions. www.findaphd.com/phds/project...